An additional mechanism of acquired resistance in EGFR mutation-positive NSCLC is transformation to the small-cell lung cancer (SCLC) phenotype, which has been reported in several patient cases [36, 108, 109]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.